{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/2006854546",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/2064197173"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#2006854546",
  "code": "5B5K.8",
  "source": "http://id.who.int/icd/entity/2006854546",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Chromium deficiency"
  },
  "definition": {
    "@language": "en",
    "@value": "Deficiency in humans is only described in long-term total parenteral nutrition patients receiving insufficient chromium. Hyperglycaemia or impaired glucose tolerance occurs. Elevated plasma free fatty acid concentrations, neuropathy, encephalopathy, and abnormalities in nitrogen metabolism are also reported."
  },
  "relatedEntitiesInMaternalChapter": [
    "http://id.who.int/icd/entity/1867773640"
  ],
  "relatedEntitiesInPerinatalChapter": [
    "http://id.who.int/icd/entity/517413026"
  ],
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Chromium deficiency"
      }
    }
  ]
}